Keywords: FDA, GSK Hiberix, vaccine supply

FDA accelerated approval of GSK’s Hiberix to help sustain adequate vaccine supply

Article | 20 August 2009

Print This

In response to shortage, the US Food and Drug Administration approved UK drug giant GlaxoSmithKline’s Hiberix, a Haemophilus influenzae ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in